BioAge Labs, Inc. (BIOA)
NASDAQ
BioAge Labs, Inc. Operating Income 2024–2025
BioAge Labs, Inc. annual/quarterly operating income history and growth rate from 2024 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- BioAge Labs, Inc. operating income for the quarter ending March 31, 2026 was -25.4 M, a 54.29% increase year-over-year.
- BioAge Labs, Inc. operating income for the twelve months ending March 31, 2026 was -89.7 M.
- BioAge Labs, Inc. annual operating income for 2025 was -92.8 M, a 18.65% increase from 2024.
- BioAge Labs, Inc. annual operating income for 2024 was -78.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
BioAge Labs, Inc. Operating Income — FAQ
BioAge Labs, Inc. (BIOA) operating income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is BioAge Labs, Inc.'s operating income?
BioAge Labs, Inc. (BIOA) reported operating income of -$93M for fiscal 2025.
Where can I see BIOA's operating income history?
The chart and table above show BioAge Labs, Inc.'s operating income by year and by quarter, including the growth rate.